California-Based Bio-Rad Laboratories Charged With FCPA Violations
A clinical diagnostic and life science research company based in California has been charged with violating the Foreign Corrupt Practices Act (FCPA) when its subsidiaries made improper payments to foreign officials in Russia, Vietnam, and Thailand in order to win business.
13 firms have been sanctioned for violating a rule primarily designed to protect retail investors in the municipal securities market.
A pair of Canadian citizens have been charged with conducting an international microcap fraud scheme by stockpiling shares in a coal mining company and funding a multi-million dollar promotional campaign to hype the stock while simultaneously dumping their shares and routing the proceeds through offshore accounts.
Enforcement actions have been announced against 10 companies for failing to make the required disclosures about financing deals and other unregistered sales that diluted their stock.
Fraud charges have been brought against the City of Allen Park, Mich., and two former city leaders in connection with a municipal bond offering to support a movie studio project within the city.
An attorney in Orange County, Calif., and two men in Massachusetts have been charged for operating a pump-and-dump scheme that defrauded investors in a Boston-based ticket brokering business.
